Delivery Order SPE2DB22D6029-SPE2DB24FU0FS
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SANDOSTATIN LAR DEPOT 30 MG KTS pharmaceutical products. This $3,914.52 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical and medical supplies to government agencies, particularly the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $39,145.20 to AmerisourceBergen Drug Corp, the prime contractor. The contract is for the provision of Sandostatin LAR Depot 30 mg medication kits. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a for-profit pharmaceutical distribution company that serves as a prime contractor for federal agencies, including...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,914.52 delivery order contract from the Defense Logistics Agency (DLA) to provide the pharmaceutical product Sandostatin LAR Depot 30 mg kits. The contract is a firm fixed price award with a completion date of February 26, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December...
- The federal contract award is for the delivery of Sandostatin LAR Depot 30 mg kits to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $7,829.04 and an Ultimate Completion Date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $33,187.08 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a period of performance through March 18, 2025, is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used in the treatment of various medical conditions. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,648.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Sandostatin LAR Depot, a specialty pharmaceutical product, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Sandostatin LAR Depot 30 mg kits. The contract is a firm fixed price delivery order with a ceiling value of $3,914.52 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this award and has also received...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $3,399.59 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for the supply of Sandostatin LAR Depot 10 mg kits. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0FSDelivery Order
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. The contract, valued at $3,914.52, has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the parent company Cencora, Inc. doing business as Amerisourcebergen is also mentioned. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 3/11/24 |